Composition
- Active ingredients
- NALOXONE HYDROCHLORIDE EQ 0.5MG BASE; PENTAZOCINE HYDROCHLORIDE EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA018733.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Talwin NX
- Active substance
- naloxone hydrochloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 16 Dec 1982
- Application
- NDA018733-001